CERE
Price
$21.05
Change
+$0.49 (+2.38%)
Updated
Sep 27, 6:59 PM EST
41 days until earnings call
LIAN
Price
$1.50
Change
-$0.00 (-0.00%)
Updated
Sep 27, 6:59 PM EST
70 days until earnings call

CERE vs LIAN ᐉ Comparison: Which is Better to Invest?

Header iconCERE vs LIAN Comparison
Open Charts CERE vs LIANBanner chart's image
Cerevel Therapeutics Holdings
Price$21.05
Change+$0.49 (+2.38%)
Volume$460.11K
CapitalizationN/A
LianBio
Price$1.50
Change-$0.00 (-0.00%)
Volume$73.74K
CapitalizationN/A
View a ticker or compare two or three
CERE vs LIAN Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CERE vs. LIAN commentary
Sep 28, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERE is a Hold and LIAN is a Hold.

COMPARISON
Comparison
Sep 28, 2023
Stock price -- (CERE: $21.05 vs. LIAN: $1.50)
Brand notoriety: CERE and LIAN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CERE: 89% vs. LIAN: 43%
Market capitalization -- CERE: $3.2B vs. LIAN: $161.82M
CERE [@Biotechnology] is valued at $3.2B. LIAN’s [@Biotechnology] market capitalization is $161.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $407B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERE’s FA Score shows that 0 FA rating(s) are green whileLIAN’s FA Score has 1 green FA rating(s).

  • CERE’s FA Score: 0 green, 5 red.
  • LIAN’s FA Score: 1 green, 4 red.
According to our system of comparison, LIAN is a better buy in the long-term than CERE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERE’s TA Score shows that 5 TA indicator(s) are bullish while LIAN’s TA Score has 4 bullish TA indicator(s).

  • CERE’s TA Score: 5 bullish, 3 bearish.
  • LIAN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CERE is a better buy in the short-term than LIAN.

Price Growth

CERE (@Biotechnology) experienced а +1.20% price change this week, while LIAN (@Biotechnology) price change was -2.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +13.45%, and the average quarterly price growth was +33.98%.

Reported Earning Dates

CERE is expected to report earnings on Nov 08, 2023.

LIAN is expected to report earnings on Dec 07, 2023.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CERE with price predictions.
OPEN
A.I.dvisor published
a Summary for LIAN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CERE($3.21B) has a higher market cap than LIAN($162M). LIAN YTD gains are higher at: -8.537 vs. CERE (-33.259). LIAN has higher annual earnings (EBITDA): -103.55M vs. CERE (-402.2M). CERE has more cash in the bank: 736M vs. LIAN (267M). LIAN has less debt than CERE: LIAN (3.3M) vs CERE (369M). CERE (0) and LIAN (0) have equivalent revenues.
CERELIANCERE / LIAN
Capitalization3.21B162M1,978%
EBITDA-402.2M-103.55M388%
Gain YTD-33.259-8.537390%
P/E RatioN/A1.55-
Revenue00-
Total Cash736M267M276%
Total Debt369M3.3M11,182%
TECHNICAL ANALYSIS
Technical Analysis
CERELIAN
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BWEB29.720.24
+0.81%
Bitwise Web3 ETF
SEF12.940.04
+0.27%
ProShares Short Financials
MIN2.65N/A
N/A
MFS Intermediate Income Trust
GMAR31.57N/A
N/A
FT Cboe Vest U.S. Eq Mod Buffr ETF - Mar
IMTM31.37-0.05
-0.16%
iShares MSCI Intl Momentum Factor ETF

CERE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERE has been loosely correlated with MDGL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CERE jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERE
1D Price
Change %
CERE100%
+2.38%
MDGL - CERE
47%
Loosely correlated
+1.70%
AXON - CERE
46%
Loosely correlated
+2.66%
BEAM - CERE
41%
Loosely correlated
+2.80%
VKTX - CERE
39%
Loosely correlated
-8.43%
SRPT - CERE
39%
Loosely correlated
+3.37%
More